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Purpose
- Retrospective assessment of disease characteristics and
outcome for the Danish cohort of Juvenile Dermatomy-
ositis (JDM) patients, 1977 – 2005.
- Evaluation of the Myositis disease activity assessment
tool (MYOACT) and Myositis intention to treat activity
index (MITAX) as prognostic tools.
Methods
Hospital records from Danish JDM patients (1977 –
2005) were reviewed. The parameters of the MYOACT and
MITAX were used for the database.
Results
53 patients were classified as JDM. The female:male ratio
was 2:1, the mean age at disease onset was 7.1 years and
the mean disease duration was 3.6 years. Most frequent
symptoms at disease onset are displayed in Table 1.
At the 5-years follow-up 34% were in remission, 30% had
ongoing disease and disease- or treatment-induced dam-
age was present in 36%. In the total follow-up period
(2–30 years) 3 patients (6%) had died, 68% were in full
remission, 13% had ongoing disease and 13% had
unknown status.
Conclusion
- Most patients had a favourable outcome; however irre-
versible damage was found in 36% at 5-years follow-up
- Baseline predictors of unfavourable disease outcome
could not be identified
- Due to frequently missing chart data MYOACT and
MITAX could not be used as a scoring tool in this retro-
spective set-up
- A clinical long-term follow-up study is warranted and
now carried out by the authors.
from 15th Paediatric Rheumatology European Society (PreS) Congress
London, UK. 14–17 September 2008
Published: 15 September 2008
Pediatric Rheumatology 2008, 6(Suppl 1):S17 doi:10.1186/1546-0096-6-S1-S17
<supplement> <title> <p>15<sup>th </sup>Paediatric Rheumatology European Society (PreS) Congress</p> </title> <editor>Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Michaël Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/PDF/1546-0096-6-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.ped-rheum.com/content/6/S1/S17
© 2008 Mathiesen et al; licensee BioMed Central Ltd. 
Table 1: Most frequent symptoms at disease onset
Symptom % of patients
Proximal muscle weakness 81
Fatigue 74
Erythema 74
Gottrons papules 70
Heliotrope 57
Arthralgia 41
Fever 32
Arthritis 30
Weight loss 30